Recent randomized controlled trials (RCTs) have transformed acute ischemic stroke (AIS) treatment by demonstrating that mechanical endovascular therapy (MET) in addition to intravenous tissue plasminogen activator (IVtPA) has superior benefit over IVtPA alone [1–6]. Here, PLAT is linked to androgen insensitivity syndrome.